Fuan Pharmaceutical (300194.SZ) subsidiary's Cefditoren Pivoxil Granules included in the National Medical Insurance Catalog

date
16/11/2026
Zhitong Finance APP News, Fuan Pharmaceutical (300194.SZ) announced that the product Cefditoren Pivoxil Granules of its wholly-owned subsidiary Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. has been newly included in the National Medical Insurance Catalog, with payment standards of 4.02 yuan (30mg/bag) and 5.94 yuan (50mg/bag), and the payment standards are valid from January 1, 2027 to December 31, 2028. Cefditoren Pivoxil Granules are mainly indicated for superficial skin infections, deep skin infections, lymphangitis and lymphadenitis, chronic pyoderma, etc. caused by susceptible bacteria.